|
Respiratory Syncytial Virus Vaccines
|
D022261 |
[Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.
] |
|
Respiratory Syncytial Virus, Bovine
|
D018112 |
[A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.
] |
|
Respiratory Syncytial Virus, Human
|
D018113 |
[The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.
] |
|
Respiratory Syncytial Viruses
|
D012136 |
[A group of viruses in the PNEUMOVIRUS genus causing respiratory infections in various mammals. Humans and cattle are most affected but infections in goats and sheep have also been reported.
] |
|
Respiratory System
|
D012137 |
[The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.
] |
|
Respiratory System Abnormalities
|
D015619 |
[Congenital structural abnormalities of the respiratory system.
] |
|
Respiratory System Agents
|
D019141 |
[Drugs used for their effects on the respiratory system.
] |
|
Respiratory Therapy
|
D012138 |
[Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.
] |
|
Respiratory Therapy Department, Hospital
|
D012139 |
[Hospital department which is responsible for the administration of diagnostic pulmonary function tests and of procedures to restore optimum pulmonary ventilation.
] |
|
Respiratory Tract Absorption
|
D065589 |
[Uptake of substances via the lung.
, Uptake of substances via the RESPIRATORY SYSTEM.
] |
|
Respiratory Tract Diseases
|
D012140 |
[Diseases involving the RESPIRATORY SYSTEM.
] |
|
Respiratory Tract Fistula
|
D016156 |
[An abnormal passage communicating between any component of the respiratory tract or between any part of the respiratory system and surrounding organs.
] |
|
Respiratory Tract Infections
|
D012141 |
[Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
] |
|
Respiratory Tract Neoplasms
|
D012142 |
[New abnormal growth of tissue in the RESPIRATORY SYSTEM.
] |
|
Respiratory Transport
|
D015657 |
[The processes of diffusion across the BLOOD-AIR BARRIER, and the chemical reactions coupled with diffusion that effect the rate of PULMONARY GAS EXCHANGE, generally at the alveolar level.
] |
|
Respiratory-Gated Imaging Techniques
|
D055425 |
[Timing the acquisition of imaging data to specific points in the breathing cycle to minimize image blurring and other motion artifacts. The images are used diagnostically and also interventionally to coordinate radiation treatment beam on/off cycles to protect healthy tissues when they move into the beam field during different times in the breathing cycle.
] |
|
Respirovirus
|
D018108 |
[A genus of the family PARAMYXOVIRIDAE (subfamily PARAMYXOVIRINAE) where all the virions have both HEMAGGLUTININ and NEURAMINIDASE activities and encode a non-structural C protein. SENDAI VIRUS is the type species.
] |
|
Respirovirus Infections
|
D010253 |
[Infections with viruses of the genus RESPIROVIRUS, family PARAMYXOVIRIDAE. Host cell infection occurs by adsorption, via HEMAGGLUTININ, to the cell surface.
] |
|
Respite Care
|
D012144 |
[Patient care provided in the home or institution intermittently in order to provide temporary relief to the family home care giver.
] |
|
Response Elements
|
D020218 |
[Nucleotide sequences, usually upstream, which are recognized by specific regulatory transcription factors, thereby causing gene response to various regulatory agents. These elements may be found in both promoter and enhancer regions.
] |